bionlp-st-ge-2016-spacy-parsed Home  

PMC:3312845 / 31396-32730 JSONTXT 24 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T13360 0-2 IN denotes In
T13361 3-6 PRP$ denotes our
T13362 7-15 JJ denotes previous
T13363 16-23 NNS denotes studies
T13364 24-25 NNP denotes [
T13365 25-28 CD denotes 5,8
T13366 28-29 NNP denotes ]
T13367 29-30 , denotes ,
T13368 31-41 NN denotes dystrophin
T13369 42-43 -LRB- denotes (
T13370 43-45 DT denotes an
T13371 46-59 NN denotes actin-binding
T13372 60-67 NN denotes protein
T13373 68-69 NNP denotes [
T13374 69-71 CD denotes 40
T13375 71-72 NNP denotes ]
T13376 72-73 -RRB- denotes )
T13377 74-90 NN denotes immunoreactivity
T13378 91-94 VBD denotes was
T13379 95-103 VBN denotes detected
T13380 104-106 IN denotes in
T13381 107-112 NN denotes blood
T13382 113-120 NNS denotes vessels
T13383 121-124 CC denotes and
T13384 125-127 IN denotes in
T13385 128-138 JJ denotes astrocytic
T13386 139-151 JJ denotes perivascular
T13387 152-160 NN denotes end-feet
T13388 160-161 , denotes ,
T13389 162-165 CC denotes and
T13390 166-169 VBD denotes was
T13391 170-184 JJ denotes down-regulated
T13392 185-187 CD denotes 12
T13393 188-191 NNS denotes hrs
T13394 192-197 IN denotes after
T13395 198-200 NNP denotes SE
T13396 201-206 RB denotes prior
T13397 207-209 TO denotes to
T13398 210-213 DT denotes the
T13399 214-224 NN denotes appearance
T13400 225-227 IN denotes of
T13401 228-237 JJ denotes vasogenic
T13402 238-243 NN denotes edema
T13403 244-247 CC denotes and
T13404 248-263 NN denotes down-regulation
T13405 264-266 IN denotes of
T13406 267-273 NNP denotes SMI-71
T13407 274-290 NN denotes immunoreactivity
T13408 290-291 . denotes .
T13409 292-296 IN denotes With
T13410 297-304 NN denotes respect
T13411 305-307 TO denotes to
T13412 308-312 DT denotes this
T13413 313-321 JJ denotes previous
T13414 322-328 NN denotes report
T13415 328-329 , denotes ,
T13416 330-337 NNS denotes changes
T13417 338-340 IN denotes in
T13418 341-344 NNP denotes SMI
T13419 345-361 NN denotes immunoreactivity
T13420 362-367 MD denotes would
T13421 368-370 VB denotes be
T13422 371-385 NNS denotes causes/results
T13423 386-388 IN denotes of
T13424 389-400 NN denotes interaction
T13425 401-408 IN denotes between
T13426 409-420 JJ denotes endothelial
T13427 421-426 NNS denotes cells
T13428 427-430 CC denotes and
T13429 431-443 JJ denotes perivascular
T13430 444-454 NNS denotes astrocytes
T13431 454-455 . denotes .
T13432 456-458 IN denotes In
T13433 459-462 DT denotes the
T13434 463-470 JJ denotes present
T13435 471-476 NN denotes study
T13436 476-477 , denotes ,
T13437 478-488 NN denotes p65-Ser276
T13438 488-489 , denotes ,
T13439 490-500 NN denotes p65-Ser311
T13440 500-501 , denotes ,
T13441 502-512 NN denotes p65-Ser529
T13442 512-513 , denotes ,
T13443 514-517 CC denotes and
T13444 518-528 NNP denotes p65-Ser536
T13445 529-544 NN denotes phosphorylation
T13446 545-548 VBD denotes was
T13447 549-557 VBN denotes observed
T13448 558-560 IN denotes in
T13449 561-571 NNS denotes astrocytes
T13450 572-581 VBG denotes following
T13451 582-584 NNP denotes SE
T13452 584-585 . denotes .
T13453 586-597 RB denotes Furthermore
T13454 597-598 , denotes ,
T13455 599-607 JJ denotes sTNFp55R
T13456 608-616 NN denotes infusion
T13457 617-628 RB denotes effectively
T13458 629-638 VBD denotes inhibited
T13459 639-649 NN denotes p65-Ser276
T13460 650-653 CC denotes and
T13461 654-679 NN denotes p65-Ser311phosphorylation
T13462 680-682 IN denotes in
T13463 683-693 NNS denotes astrocytes
T13464 694-703 VBG denotes following
T13465 704-706 NNP denotes SE
T13466 706-707 . denotes .
T13467 708-717 RB denotes Therefore
T13468 717-718 , denotes ,
T13469 719-721 PRP denotes it
T13470 722-724 VBZ denotes is
T13471 725-731 JJ denotes likely
T13472 732-736 IN denotes that
T13473 737-745 JJ denotes enhanced
T13474 746-756 NN denotes p65-Ser276
T13475 757-760 CC denotes and
T13476 761-771 NN denotes p65-Ser311
T13477 772-787 NN denotes phosphorylation
T13478 788-791 MD denotes may
T13479 792-794 VB denotes be
T13480 795-803 VBN denotes involved
T13481 804-806 IN denotes in
T13482 807-821 JJ denotes TNF-α-mediated
T13483 822-825 NNP denotes BBB
T13484 826-836 NN denotes disruption
T13485 836-837 . denotes .
T13486 838-845 RB denotes However
T13487 845-846 , denotes ,
T13488 847-855 JJ denotes sTNFp55R
T13489 856-864 NN denotes infusion
T13490 865-870 MD denotes could
T13491 871-874 RB denotes not
T13492 875-882 VB denotes prevent
T13493 883-893 NN denotes p65-Ser529
T13494 894-897 CC denotes and
T13495 898-908 NN denotes p65-Ser536
T13496 909-925 NNS denotes phosphorylations
T13497 926-930 IN denotes from
T13498 931-933 JJ denotes SE
T13499 934-941 NNS denotes insults
T13500 941-942 . denotes .
T13501 943-948 IN denotes Since
T13502 949-959 NN denotes p65-Ser529
T13503 960-963 CC denotes and
T13504 964-974 NN denotes p65-Ser536
T13505 975-978 VBP denotes are
T13506 979-993 VBN denotes phosphorylated
T13507 994-996 IN denotes by
T13508 997-1002 NNP denotes TNF-α
T13509 1003-1006 CC denotes and
T13510 1007-1012 NNP denotes IL-1β
T13511 1013-1014 NNP denotes [
T13512 1014-1016 CD denotes 41
T13513 1016-1017 NNP denotes ]
T13514 1017-1018 , denotes ,
T13515 1019-1021 PRP denotes it
T13516 1022-1024 VBZ denotes is
T13517 1025-1031 JJ denotes likely
T13518 1032-1036 IN denotes that
T13519 1037-1051 JJ denotes IL-1β-mediated
T13520 1052-1062 JJ denotes p65-Ser529
T13521 1062-1063 NN denotes /
T13522 1063-1069 NNP denotes Ser536
T13523 1070-1085 NN denotes phosphorylation
T13524 1086-1089 MD denotes may
T13525 1090-1094 RB denotes also
T13526 1095-1099 VB denotes play
T13527 1100-1101 DT denotes a
T13528 1102-1106 NN denotes role
T13529 1107-1109 IN denotes in
T13530 1110-1120 JJ denotes SE-induced
T13531 1121-1130 JJ denotes vasogenic
T13532 1131-1136 NN denotes edema
T13533 1136-1137 . denotes .
T13534 1138-1147 RB denotes Therefore
T13535 1147-1148 , denotes ,
T13536 1149-1152 PRP$ denotes our
T13537 1153-1161 NNS denotes findings
T13538 1162-1170 VBP denotes indicate
T13539 1171-1175 IN denotes that
T13540 1176-1180 DT denotes both
T13541 1181-1186 NNP denotes TNF-α
T13542 1187-1190 CC denotes and
T13543 1191-1196 NNP denotes IL-1β
T13544 1197-1200 MD denotes may
T13545 1201-1203 VB denotes be
T13546 1204-1214 NNS denotes synergists
T13547 1215-1217 TO denotes to
T13548 1218-1222 VB denotes play
T13549 1223-1229 CC denotes either
T13550 1230-1231 DT denotes a
T13551 1232-1238 JJ denotes direct
T13552 1239-1240 -LRB- denotes (
T13553 1240-1242 IN denotes by
T13554 1243-1254 JJ denotes endothelial
T13555 1255-1260 NNS denotes cells
T13556 1260-1261 -RRB- denotes )
T13557 1262-1264 CC denotes or
T13558 1265-1273 JJ denotes indirect
T13559 1274-1275 -LRB- denotes (
T13560 1275-1277 IN denotes by
T13561 1278-1288 NNS denotes astrocytes
T13562 1288-1289 -RRB- denotes )
T13563 1290-1294 NN denotes role
T13564 1295-1297 IN denotes in
T13565 1298-1301 DT denotes the
T13566 1302-1313 NN denotes maintenance
T13567 1314-1316 IN denotes of
T13568 1317-1320 NNP denotes BBB
T13569 1321-1333 NN denotes permeability
T13570 1333-1334 . denotes .
R10547 T13360 T13379 prep In,detected
R10548 T13361 T13363 poss our,studies
R10549 T13362 T13363 amod previous,studies
R10550 T13363 T13360 pobj studies,In
R10551 T13364 T13366 compound [,]
R10552 T13365 T13366 compound "5,8",]
R10553 T13366 T13379 nsubjpass ],detected
R10554 T13367 T13366 punct ",",]
R10555 T13368 T13377 amod dystrophin,immunoreactivity
R10556 T13369 T13372 punct (,protein
R10557 T13370 T13372 det an,protein
R10558 T13371 T13372 compound actin-binding,protein
R10559 T13372 T13377 nmod protein,immunoreactivity
R10560 T13373 T13377 nmod [,immunoreactivity
R10561 T13374 T13375 nummod 40,]
R10562 T13375 T13373 appos ],[
R10563 T13376 T13377 punct ),immunoreactivity
R10564 T13377 T13379 nsubjpass immunoreactivity,detected
R10565 T13378 T13379 auxpass was,detected
R10566 T13379 T13379 ROOT detected,detected
R10567 T13380 T13379 prep in,detected
R10568 T13381 T13382 compound blood,vessels
R10569 T13382 T13380 pobj vessels,in
R10570 T13383 T13380 cc and,in
R10571 T13384 T13380 conj in,in
R10572 T13385 T13387 amod astrocytic,end-feet
R10573 T13386 T13387 amod perivascular,end-feet
R10574 T13387 T13384 pobj end-feet,in
R10575 T13388 T13379 punct ",",detected
R10576 T13389 T13379 cc and,detected
R10577 T13390 T13379 conj was,detected
R10578 T13391 T13390 acomp down-regulated,was
R10579 T13392 T13393 nummod 12,hrs
R10580 T13393 T13391 npadvmod hrs,down-regulated
R10581 T13394 T13390 prep after,was
R10582 T13395 T13396 nsubj SE,prior
R10583 T13396 T13390 advmod prior,was
R10584 T13397 T13396 prep to,prior
R10585 T13398 T13399 det the,appearance
R10586 T13399 T13397 pobj appearance,to
R10587 T13400 T13399 prep of,appearance
R10588 T13401 T13402 amod vasogenic,edema
R10589 T13402 T13400 pobj edema,of
R10590 T13403 T13402 cc and,edema
R10591 T13404 T13402 conj down-regulation,edema
R10592 T13405 T13402 prep of,edema
R10593 T13406 T13407 compound SMI-71,immunoreactivity
R10594 T13407 T13405 pobj immunoreactivity,of
R10595 T13408 T13379 punct .,detected
R10596 T13409 T13421 prep With,be
R10597 T13410 T13409 pobj respect,With
R10598 T13411 T13410 prep to,respect
R10599 T13412 T13414 det this,report
R10600 T13413 T13414 amod previous,report
R10601 T13414 T13411 pobj report,to
R10602 T13415 T13421 punct ",",be
R10603 T13416 T13421 nsubj changes,be
R10604 T13417 T13416 prep in,changes
R10605 T13418 T13419 compound SMI,immunoreactivity
R10606 T13419 T13417 pobj immunoreactivity,in
R10607 T13420 T13421 aux would,be
R10608 T13421 T13421 ROOT be,be
R10609 T13422 T13421 attr causes/results,be
R10610 T13423 T13422 prep of,causes/results
R10611 T13424 T13423 pobj interaction,of
R10612 T13425 T13424 prep between,interaction
R10613 T13426 T13427 amod endothelial,cells
R10614 T13427 T13425 pobj cells,between
R10615 T13428 T13427 cc and,cells
R10616 T13429 T13430 amod perivascular,astrocytes
R10617 T13430 T13427 conj astrocytes,cells
R10618 T13431 T13421 punct .,be
R10619 T13432 T13447 prep In,observed
R10620 T13433 T13435 det the,study
R10621 T13434 T13435 amod present,study
R10622 T13435 T13432 pobj study,In
R10623 T13436 T13447 punct ",",observed
R10624 T13437 T13447 nsubjpass p65-Ser276,observed
R10625 T13438 T13437 punct ",",p65-Ser276
R10626 T13439 T13437 conj p65-Ser311,p65-Ser276
R10627 T13440 T13439 punct ",",p65-Ser311
R10628 T13441 T13439 conj p65-Ser529,p65-Ser311
R10629 T13442 T13441 punct ",",p65-Ser529
R10630 T13443 T13441 cc and,p65-Ser529
R10631 T13444 T13445 compound p65-Ser536,phosphorylation
R10632 T13445 T13441 conj phosphorylation,p65-Ser529
R10633 T13446 T13447 auxpass was,observed
R10634 T13447 T13447 ROOT observed,observed
R10635 T13448 T13447 prep in,observed
R10636 T13449 T13448 pobj astrocytes,in
R10637 T13450 T13449 prep following,astrocytes
R10638 T13451 T13450 dobj SE,following
R10639 T13452 T13447 punct .,observed
R10640 T13453 T13458 advmod Furthermore,inhibited
R10641 T13454 T13458 punct ",",inhibited
R10642 T13455 T13456 amod sTNFp55R,infusion
R10643 T13456 T13458 nsubj infusion,inhibited
R10644 T13457 T13458 advmod effectively,inhibited
R10645 T13458 T13458 ROOT inhibited,inhibited
R10646 T13459 T13458 dobj p65-Ser276,inhibited
R10647 T13460 T13459 cc and,p65-Ser276
R10648 T13461 T13459 conj p65-Ser311phosphorylation,p65-Ser276
R10649 T13462 T13458 prep in,inhibited
R10650 T13463 T13462 pobj astrocytes,in
R10651 T13464 T13463 prep following,astrocytes
R10652 T13465 T13464 pobj SE,following
R10653 T13466 T13458 punct .,inhibited
R10654 T13467 T13470 advmod Therefore,is
R10655 T13468 T13470 punct ",",is
R10656 T13469 T13470 nsubj it,is
R10657 T13470 T13470 ROOT is,is
R10658 T13471 T13470 acomp likely,is
R10659 T13472 T13480 mark that,involved
R10660 T13473 T13474 amod enhanced,p65-Ser276
R10661 T13474 T13480 nsubjpass p65-Ser276,involved
R10662 T13475 T13474 cc and,p65-Ser276
R10663 T13476 T13477 compound p65-Ser311,phosphorylation
R10664 T13477 T13474 conj phosphorylation,p65-Ser276
R10665 T13478 T13480 aux may,involved
R10666 T13479 T13480 auxpass be,involved
R10667 T13480 T13470 ccomp involved,is
R10668 T13481 T13480 prep in,involved
R10669 T13482 T13483 compound TNF-α-mediated,BBB
R10670 T13483 T13484 compound BBB,disruption
R10671 T13484 T13481 pobj disruption,in
R10672 T13485 T13470 punct .,is
R10673 T13486 T13492 advmod However,prevent
R10674 T13487 T13492 punct ",",prevent
R10675 T13488 T13489 amod sTNFp55R,infusion
R10676 T13489 T13492 nsubj infusion,prevent
R10677 T13490 T13492 aux could,prevent
R10678 T13491 T13492 neg not,prevent
R10679 T13492 T13492 ROOT prevent,prevent
R10680 T13493 T13492 dobj p65-Ser529,prevent
R10681 T13494 T13493 cc and,p65-Ser529
R10682 T13495 T13493 conj p65-Ser536,p65-Ser529
R10683 T13496 T13493 conj phosphorylations,p65-Ser529
R10684 T13497 T13496 prep from,phosphorylations
R10685 T13498 T13499 compound SE,insults
R10686 T13499 T13497 pobj insults,from
R10687 T13500 T13492 punct .,prevent
R10688 T13501 T13506 mark Since,phosphorylated
R10689 T13502 T13505 nsubj p65-Ser529,are
R10690 T13503 T13502 cc and,p65-Ser529
R10691 T13504 T13502 conj p65-Ser536,p65-Ser529
R10692 T13505 T13506 auxpass are,phosphorylated
R10693 T13506 T13516 advcl phosphorylated,is
R10694 T13507 T13506 agent by,phosphorylated
R10695 T13508 T13507 pobj TNF-α,by
R10696 T13509 T13508 cc and,TNF-α
R10697 T13510 T13511 compound IL-1β,[
R10698 T13511 T13508 conj [,TNF-α
R10699 T13512 T13513 nummod 41,]
R10700 T13513 T13513 ROOT ],]
R10701 T13514 T13516 punct ",",is
R10702 T13515 T13516 nsubj it,is
R10703 T13516 T13516 ROOT is,is
R10704 T13517 T13516 acomp likely,is
R10705 T13518 T13526 mark that,play
R10706 T13519 T13523 amod IL-1β-mediated,phosphorylation
R10707 T13520 T13521 amod p65-Ser529,/
R10708 T13521 T13523 compound /,phosphorylation
R10709 T13522 T13523 compound Ser536,phosphorylation
R10710 T13523 T13526 nsubj phosphorylation,play
R10711 T13524 T13526 aux may,play
R10712 T13525 T13526 advmod also,play
R10713 T13526 T13517 ccomp play,likely
R10714 T13527 T13528 det a,role
R10715 T13528 T13526 dobj role,play
R10716 T13529 T13528 prep in,role
R10717 T13530 T13532 amod SE-induced,edema
R10718 T13531 T13532 amod vasogenic,edema
R10719 T13532 T13529 pobj edema,in
R10720 T13533 T13516 punct .,is
R10721 T13534 T13538 advmod Therefore,indicate
R10722 T13535 T13538 punct ",",indicate
R10723 T13536 T13537 poss our,findings
R10724 T13537 T13538 nsubj findings,indicate
R10725 T13538 T13563 nmod indicate,role
R10726 T13539 T13545 mark that,be
R10727 T13540 T13541 preconj both,TNF-α
R10728 T13541 T13545 nsubj TNF-α,be
R10729 T13542 T13541 cc and,TNF-α
R10730 T13543 T13541 conj IL-1β,TNF-α
R10731 T13544 T13545 aux may,be
R10732 T13545 T13538 ccomp be,indicate
R10733 T13546 T13545 attr synergists,be
R10734 T13547 T13548 aux to,play
R10735 T13548 T13545 xcomp play,be
R10736 T13549 T13553 preconj either,by
R10737 T13550 T13553 det a,by
R10738 T13551 T13553 amod direct,by
R10739 T13552 T13553 punct (,by
R10740 T13553 T13548 prep by,play
R10741 T13554 T13555 amod endothelial,cells
R10742 T13555 T13553 pobj cells,by
R10743 T13556 T13538 punct ),indicate
R10744 T13557 T13538 cc or,indicate
R10745 T13558 T13538 conj indirect,indicate
R10746 T13559 T13560 punct (,by
R10747 T13560 T13558 prep by,indirect
R10748 T13561 T13560 pobj astrocytes,by
R10749 T13562 T13563 punct ),role
R10750 T13563 T13563 ROOT role,role
R10751 T13564 T13563 prep in,role
R10752 T13565 T13566 det the,maintenance
R10753 T13566 T13564 pobj maintenance,in
R10754 T13567 T13566 prep of,maintenance
R10755 T13568 T13569 compound BBB,permeability
R10756 T13569 T13567 pobj permeability,of
R10757 T13570 T13563 punct .,role